FORMULATIONS AND DOSAGE AMOUNTS FOR ADMINISTERING AN ANTI-DPP3 ANTIBODY OR FRAGMENT THEREOF TO HUMANS
Application
US20260083672A1
Kind: A1
Mar 26, 2026
Assignee
4TEEN4 Pharmaceuticals GmbH
Inventors
Andreas Bergmann, Karine Bourgeois
Abstract
The present inventions are directed to formulations and dosage amounts for the administration of a humanized anti-DPP3 antibody or fragment thereof to humans, including for the treatment of life-threatening circulatory failure conditions, such as shock.
CPC Classifications
A61K 9/08
A61K 9/0019
A61K 47/20
A61K 47/22
A61K 47/26
C07K 16/40
A61K 2039/505
A61K 2039/545
C07K 2317/24
C07K 2317/76
C07K 2317/92
Filing Date
2025-08-26
Application No.
19310528